West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
302.20
-3.96 (-1.29%)
At close: Apr 27, 2026, 4:00 PM EDT
302.20
0.00 (0.00%)
After-hours: Apr 27, 2026, 4:44 PM EDT
WST Stock Forecast
Stock Price Forecast
The 7 analysts that cover WST stock have a consensus rating of "Buy" and an average price target of $325.86, which forecasts a 7.83% increase in the stock price over the next year. The lowest target is $285 and the highest is $355.
Price Target: $325.86 (+7.83%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for WST stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $275 → $310 | Hold | Maintains | $275 → $310 | +2.58% | Apr 27, 2026 |
| Barclays | Barclays | Hold Maintains $265 → $275 | Hold | Maintains | $265 → $275 | -9.00% | Apr 14, 2026 |
| Barclays | Barclays | Hold Maintains $325 → $265 | Hold | Maintains | $325 → $265 | -12.31% | Feb 13, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $390 → $320 | Buy | Maintains | $390 → $320 | +5.89% | Feb 3, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $285 | Hold | Initiates | $285 | -5.69% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
3.28B
from 3.07B
Increased by 6.76%
Revenue Next Year
3.49B
from 3.28B
Increased by 6.22%
EPS This Year
8.11
from 6.79
Increased by 19.43%
EPS Next Year
8.99
from 8.11
Increased by 10.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.4B | 3.7B | |||
| Avg | 3.3B | 3.5B | |||
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.8% | 12.5% | |||
| Avg | 6.8% | 6.2% | |||
| Low | 2.9% | 0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.62 | 9.76 | |||
| Avg | 8.11 | 8.99 | |||
| Low | 7.74 | 8.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 27.0% | 20.4% | |||
| Avg | 19.4% | 10.8% | |||
| Low | 14.0% | 1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.